Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Oric Pharmaceuticals (ORIC) Assets Average (2020 - 2026)

Oric Pharmaceuticals filings provide 7 years of Assets Average readings, the most recent being $422.8 million for Q1 2026.

  • Quarterly Assets Average rose 63.57% to $422.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $422.8 million through Mar 2026, up 63.57% year-over-year, with the annual reading at $341.5 million for FY2025, 29.82% up from the prior year.
  • Assets Average hit $422.8 million in Q1 2026 for Oric Pharmaceuticals, up from $420.0 million in the prior quarter.
  • Across five years, Assets Average topped out at $422.8 million in Q1 2026 and bottomed at $236.9 million in Q1 2023.
  • Average Assets Average over 5 years is $301.1 million, with a median of $286.9 million recorded in 2022.
  • The largest annual shift saw Assets Average dropped 20.83% in 2022 before it surged 63.57% in 2026.
  • Oric Pharmaceuticals' Assets Average stood at $242.6 million in 2022, then increased by 8.48% to $263.2 million in 2023, then increased by 9.47% to $288.1 million in 2024, then surged by 45.79% to $420.0 million in 2025, then rose by 0.66% to $422.8 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Assets Average are $422.8 million (Q1 2026), $420.0 million (Q4 2025), and $389.0 million (Q3 2025).